Cargando…
Immune‐checkpoint molecules on regulatory T‐cells as a potential therapeutic target in head and neck squamous cell cancers
Immune‐checkpoint inhibitors improve the survival of head and neck squamous cell carcinoma (HNSCC) patients. Although recent studies have demonstrated that the tumor immune microenvironment (TIME) has critical roles in immunotherapy, the precise mechanisms involved are unclear. Therefore, further in...
Autores principales: | Suzuki, Susumu, Ogawa, Tetsuya, Sano, Rui, Takahara, Taishi, Inukai, Daisuke, Akira, Satou, Tsuchida, Hiromi, Yoshikawa, Kazuhiro, Ueda, Ryuzo, Tsuzuki, Toyonori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7293074/ https://www.ncbi.nlm.nih.gov/pubmed/32304268 http://dx.doi.org/10.1111/cas.14422 |
Ejemplares similares
-
Immune Status of Cervical Lymph Nodes in Head and Neck Cancer—A Surgical Oncology Perspective
por: Nakamura, Hiromu, et al.
Publicado: (2023) -
In Situ PD-L1 Expression in Oral Squamous Cell Carcinoma Is Induced by Heterogeneous Mechanisms among Patients
por: Kondo, Yutaro, et al.
Publicado: (2022) -
Establishment of Mucoepidermoid Carcinoma Cell Lines from Surgical and Recurrence Biopsy Specimens
por: Yamanaka, Shunpei, et al.
Publicado: (2023) -
Improving function of cytotoxic T‐lymphocytes by transforming growth factor‐β inhibitor in oral squamous cell carcinoma
por: Kondo, Yutaro, et al.
Publicado: (2021) -
Trametinib improves Treg selectivity of anti-CCR4 antibody by regulating CCR4 expression in CTLs in oral squamous cell carcinoma
por: Ono, Shoya, et al.
Publicado: (2022)